Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Acetylmethionine is a derivative of the amino acid L-methionine in which an acetyl group is attached to the nitrogen atom. It is used experimentally as a nutritional supplement and for peritoneal dialysis in patients with renal failure or nutritional deficiency[1][2]. N-Acetylmethionine participates in methylation and transsulfuration metabolic pathways, serving as a biologically available, N-terminal capped form of methionine[5][6]. Its mechanism involves conversion to methionine and interaction with enzymes such as N-succinylamino acid racemase; it also plays roles in protein stability through N-terminal acetylation[1][5][6]. The compound has been studied for effects on cell growth, mitochondrial activity, and protein synthesis but remains primarily experimental without established pharmaceutical indications[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-Acetylmethionine.